Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-28, Stock:ABT, The news for the past five days is as follows:
2019-02-21: NEWS1: Abbott (ABT) Dips More Than Broader Markets: What You Should Know.NEWS2: Medidata's (MDSO) Margins Under Pressure, Competition Rife.NEWS3: Medidata's (MDSO) Margins Under Pressure, Competition Rife.NEWS4: Here Are the Key Growth Catalysts for Abbott Laboratories in 2019.NEWS5: New Real-World Evidence Analysis of Nearly Half a Million FreeStyle® Libre System Users Shows Higher Rates of Scanning Improves Glucose Control.NEWS6: Medidata's (MDSO) Margins Under Pressure, Competition Rife.NEWS7: Will Boston Scientific or Abbott Report Higher Margins?.NEWS8: Boston Scientific or Abbott: Who Is Controlling Expenses Better?.
2019-02-22: NEWS1: Abbott Laboratories (ABT) Files 10-K for the Fiscal Year Ended on December 31, 2018.NEWS2: Quest Diagnostics Grows on Innovation Amid Reimbursement Woe.NEWS3: Quest Diagnostics Grows on Innovation Amid Reimbursement Woe.NEWS4: Daily Dividend Report: PLD, SRE, DLR, ABT, CCI.NEWS5: Daily Dividend Report: PLD, SRE, DLR, ABT, CCI.NEWS6: Abbott planning $62M expansion in Columbus, adding 38 jobs.NEWS7: Why Is Abbott (ABT) Up 6% Since Last Earnings Report?.NEWS8: Why Is Abbott (ABT) Up 6% Since Last Earnings Report?.NEWS9: Here's Why Investors Should Hold DaVita (DVA) Stock Now.NEWS10: Here's Why Investors Should Hold DaVita (DVA) Stock Now.NEWS11: Quest Diagnostics Grows on Innovation Amid Reimbursement Woe.NEWS12: Abbott Declares 381st Consecutive Quarterly Dividend.NEWS13: NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall.NEWS14: NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall.NEWS15: Why Is Abbott (ABT) Up 6% Since Last Earnings Report?.NEWS16: Here's Why Investors Should Hold DaVita (DVA) Stock Now.NEWS17: NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall.NEWS18: Abbott (ABT) Dips More Than Broader Markets: What You Should Know.NEWS19: Abbott (ABT) Dips More Than Broader Markets: What You Should Know.
2019-02-25: NEWS1: Big Pharma to testify in Senate drug pricing hearing.NEWS2: See what the IHS Markit Score report has to say about Abbott Laboratories..NEWS3: CVS Health Rides on Aetna Synergy, PBM Selling Season Modest.NEWS4: CVS Health Rides on Aetna Synergy, PBM Selling Season Modest.NEWS5: Chemed (CHE) Q4 Earnings Beat Estimates, Gross Margin Falls.NEWS6: Chemed (CHE) Q4 Earnings Beat Estimates, Gross Margin Falls.NEWS7: Abbott to Present at Barclays Global Healthcare Conference.NEWS8: CVS Health Rides on Aetna Synergy, PBM Selling Season Modest.NEWS9: Chemed (CHE) Q4 Earnings Beat Estimates, Gross Margin Falls.
2019-02-26: NEWS1: Bruker Rides on Robust NANO & CALID Groups, Recent Buyouts.NEWS2: Here's Why Investors Should Buy DexCom (DXCM) Stock Now.NEWS3: [$$] CEOs From Pfizer, Merck and Others Face Senate Over Drug Pricing.NEWS4: Teleflex (TFX) Q4 Earnings Miss Estimates, Margins Rise.NEWS5: Teleflex (TFX) Q4 Earnings Miss Estimates, Margins Rise.NEWS6: Teleflex (TFX) Q4 Earnings Miss Estimates, Margins Rise.NEWS7: Stryker Expands Acquisition Portfolio With Arrinex Buyout.NEWS8: Stryker Expands Acquisition Portfolio With Arrinex Buyout.NEWS9: Stryker Expands Acquisition Portfolio With Arrinex Buyout.
2019-02-27: NEWS1: Veeva Systems (VEEV) Beats on Q4 Earnings and Revenues.NEWS2: Veeva Systems (VEEV) Beats on Q4 Earnings and Revenues.NEWS3: Wright Medical (WMGI) Q4 Earnings & Revenues Beat Estimates.NEWS4: Wright Medical (WMGI) Q4 Earnings & Revenues Beat Estimates.NEWS5: Veeva Systems (VEEV) Beats on Q4 Earnings and Revenues.NEWS6: Wright Medical (WMGI) Q4 Earnings & Revenues Beat Estimates.NEWS7: Report: Developing Opportunities within Abbott Laboratories, American Express, Welbilt, Cinemark, Barnes Group, and Nevsun Resources — Future Expectations, Projections Moving into 2019.NEWS8: Here's Why Investors Should Buy DexCom (DXCM) Stock Now.NEWS9: Here's Why Investors Should Buy DexCom (DXCM) Stock Now.NEWS10: Bruker Rides on Robust NANO & CALID Groups, Recent Buyouts.NEWS11: Bruker Rides on Robust NANO & CALID Groups, Recent Buyouts.

Answer: Rise